US2003148933A1PendingUtilityA1
Derivatives of dehydrodidemnin B
Est. expiryOct 1, 2010(expired)· nominal 20-yr term from priority
A61K 38/12C07K 5/0205C07K 11/02
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Dehydrodidemnin with useful biological activity has formula (1). It can be isolated from natural sources or synthesized, and it forms active derivatives.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . The substantially pure compound, Dehydrodidemnin B, essentially free of the cellular debris of the Mediterranean tunicate, Aplidium albicans , said compound having the formula:
2 . An acylated, alkylated or arylated derivative of dehydrodidemnin B wherein the acyl, alkyl, or aryl groups are selected from C 1 to C 6 alkyl, C 1 to C 6 acyl, phenyl, benzyl, or C 1 to C 6 alkylphenyl.
3 . A pharmaceutical composition which comprises dehydrodidemnin B or an active acylated, alkylated or arylated derivative thereof, together with a pharmaceutically acceptable carrier, wherein the acyl, alkyl, or aryl groups are selected from either C 1 to C 6 alkyl, C 1 to C 6 acyl, phenyl, benzyl, or C 1 to C 6 alkylphenyl.
4 . A semisynthetic process for the preparation of dehydrodidemnin B, which comprises the coupling of pyruvyl-proline to didemnin A.
5 . A method for isolation of dehydrodidemnin B which comprises extraction from a dehydrodidemnin B-containing tunicate.
6 . The monoacetyl derivative of dehydrodidemnin B.Join the waitlist — get patent alerts
Track US2003148933A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.